Genentech - Alchetron, The Free Social Encyclopedia
alchetron.com
Genentech - Alchetron, The Free Social Encyclopedia
Genentech, Inc., is a biotechnology corporation which became a subsidiary of Roche in 2009. Genentech Research and Early Development operates as an independent center within Roche. As of September 2016, Genentech employed 14,815 people. The company was founded in 1976 by venture capitalist Robert A.
Apr 7, 2016
Related Products
Genentech Inc. Logo
Alexander Hardy Genentech
UCSF Genentech Hall
#Genentech Breakthroughs
SanegeneBio annonce une collaboration mondiale de licence sur l'ARNi avec Genentech
SanegeneBio annonce une collaboration mondiale de licence sur l'ARNi avec Genentech
zonebourse.com2 months ago
Can AI save lives by accelerating inclusive clinical research? In this session, top health-care professionals and tech experts explore the transformative potential of AI through an interactive live podcast recording and share their efforts to advance clinical research by expanding to underrepresented patients, minimizing perpetuating human biases and widening health-equity gaps. This session is produced by our underwriter and is independent of The Atlantic’s editorial staff. | AtlanticLIVE
Can AI save lives by accelerating inclusive clinical research? In this session, top health-care professionals and tech experts explore the transformative potential of AI through an interactive live podcast recording and share their efforts to advance clinical research by expanding to underrepresented patients, minimizing perpetuating human biases and widening health-equity gaps. This session is produced by our underwriter and is independent of The Atlantic’s editorial staff. | AtlanticLIVE
FacebookSep 22, 2024
Top videos
Genentech on Reels
0:07
Genentech on Reels
FacebookGenentech
63 viewsOct 4, 2022
In September, we celebrated the 30th anniversary of our annual Genentech Goes to Town program in South San Francisco. Over the program’s two-week period, our employees headed into town to support local businesses in SSF and the areas near our larger sites in California and Oregon, bringing our total investment to $4.6M in 300 merchants. Watch the video below to see highlights from Genentech Goes to Town, and learn more about our longstanding commitment to investing in our local communities at ht
0:21
In September, we celebrated the 30th anniversary of our annual Genentech Goes to Town program in South San Francisco. Over the program’s two-week period, our employees headed into town to support local businesses in SSF and the areas near our larger sites in California and Oregon, bringing our total investment to $4.6M in 300 merchants. Watch the video below to see highlights from Genentech Goes to Town, and learn more about our longstanding commitment to investing in our local communities at ht
FacebookGenentech
979 viewsOct 4, 2023
Genentech | LinkedIn
Genentech | LinkedIn
linkedin.com
Jan 1, 2009
Genentech Careers
Careers - Wilhelmsen
Careers - Wilhelmsen
wilhelmsen.com
Mar 2, 2016
Graduates
Graduates
novartis.com
Aug 28, 2023
Careers | RailWorks
Careers | RailWorks
railworks.com
Oct 7, 2017
Genentech on Reels
0:07
Genentech on Reels
63 viewsOct 4, 2022
FacebookGenentech
In September, we celebrated the 30th anniversary of our annual Genentech Goes to Town program in South San Francisco. Over the program’s two-week period, our employees headed into town to support local businesses in SSF and the areas near our larger sites in California and Oregon, bringing our total investment to $4.6M in 300 merchants. Watch the video below to see highlights from Genentech Goes to Town, and learn more about our longstanding commitment to investing in our local communities at ht
0:21
In September, we celebrated the 30th anniversary of our annual Genentech Goes to Town program in South San Francisco. Over the program’s two-week period, our employees headed into town to support local businesses in SSF and the areas near our larger sites in California and Oregon, bringing our total investment to $4.6M in 300 merchants. Watch the video below to see highlights from Genentech Goes to Town, and learn more about our longstanding commitment to investing in our local communities at ht
979 viewsOct 4, 2023
FacebookGenentech
Genentech | LinkedIn
Genentech | LinkedIn
Jan 1, 2009
linkedin.com
Genentech Closes Cancer Immunology Department | Immunology
Genentech Closes Cancer Immunology Department | Immunology
Aug 22, 2024
labroots.com
Genentech & U.S. Roche
Genentech & U.S. Roche
Oct 6, 2022
lyrahealth.com
Genentech breaks ground in Holly Springs
Genentech breaks ground in Holly Springs
7 months ago
wral.com
When first diagnosed with triple-negative breast cancer, Latasha learned the aggressive disease disproportionately affects African American women. She hopes continued research and disease education will lead to a brighter future for the next generation. | Genentech
0:24
When first diagnosed with triple-negative breast cancer, Latasha learned the aggressive disease disproportionately affects African American women. She hopes continued research and disease education will lead to a brighter future for the next generation. | Genentech
55.1K viewsOct 9, 2019
FacebookGenentech
Let’s face it: smoking used to be everywhere. But when it comes to facing lung cancer today, you’ve got more power than you think. We’re teaming up with Genentech to encourage those at risk to get screened for lung cancer. Learn who’s eligible at ScreenYourLungs.org | American Cancer Society
0:11
Let’s face it: smoking used to be everywhere. But when it comes to facing lung cancer today, you’ve got more power than you think. We’re teaming up with Genentech to encourage those at risk to get screened for lung cancer. Learn who’s eligible at ScreenYourLungs.org | American Cancer Society
5.2K viewsJul 1, 2021
FacebookAmerican Cancer Society
Nasal polyps is a chronic condition that impacts approximately 13 million Americans and is most common in those who have allergies or asthma. It can cause symptoms like congestion, difficulty breathing through the nose, or loss of smell. Watch the video below to learn more about nasal polyps and potential ways to manage it. | Genentech
1:20
Nasal polyps is a chronic condition that impacts approximately 13 million Americans and is most common in those who have allergies or asthma. It can cause symptoms like congestion, difficulty breathing through the nose, or loss of smell. Watch the video below to learn more about nasal polyps and potential ways to manage it. | Genentech
101.4K viewsDec 7, 2020
FacebookGenentech
Listen to our own Fred Brown, Healthcare Market Director, talk about his career at Genentech and how we’re actively working to foster belonging in our workforce. Bring your unique perspective to our diverse team: https://bit.ly/3MBF6mM | Genentech Jobs
1:19
Listen to our own Fred Brown, Healthcare Market Director, talk about his career at Genentech and how we’re actively working to foster belonging in our workforce. Bring your unique perspective to our diverse team: https://bit.ly/3MBF6mM | Genentech Jobs
110.4K viewsMay 17, 2022
FacebookGenentech Jobs
No two breast cancer journeys are the same, and biomarker testing plays an important role in leading to a more personalized treatment approach from the outset. Megan O’Neil, a breast cancer survivor, shares how biomarker testing helped identify the PIK3CA mutation in her tumor. | Genentech
1:01
No two breast cancer journeys are the same, and biomarker testing plays an important role in leading to a more personalized treatment approach from the outset. Megan O’Neil, a breast cancer survivor, shares how biomarker testing helped identify the PIK3CA mutation in her tumor. | Genentech
79.6K viewsDec 12, 2024
FacebookGenentech
What does it look like when local voices lead the way in shaping healthcare? Real, lasting change. True progress happens when we listen to, and partner directly with, the people who know their communities best. We’re working hand-in-hand with local leaders and organizations to break down barriers to care, support health education and expand access to clinical research for underserved communities. It’s about building trust to create a healthier and more equitable future, together. Read the powerf
0:31
What does it look like when local voices lead the way in shaping healthcare? Real, lasting change. True progress happens when we listen to, and partner directly with, the people who know their communities best. We’re working hand-in-hand with local leaders and organizations to break down barriers to care, support health education and expand access to clinical research for underserved communities. It’s about building trust to create a healthier and more equitable future, together. Read the powerf
28.9K views7 months ago
FacebookGenentech
Genentech to close South SF production facility, lay off more than 250 employees, company says
Genentech to close South SF production facility, lay off more than 250 employees, company says
Mar 28, 2023
ABC7 San Francisco
Genentech: Genentech Goes to Town
Genentech: Genentech Goes to Town
Feb 20, 2022
gene.com
Growing up, John Marioni wasn’t always sure the exact path his career would take, but he ultimately found his calling at the intersection of computational science and biology, where he takes a human-centric approach to AI applications. Now, as our Head of Computational Sciences, John and his team are revolutionizing drug discovery through AI and machine learning. Under John’s leadership, the team works in harmony with AI to establish a powerful new tempo for drug development: http://spr.ly/6180t
0:12
Growing up, John Marioni wasn’t always sure the exact path his career would take, but he ultimately found his calling at the intersection of computational science and biology, where he takes a human-centric approach to AI applications. Now, as our Head of Computational Sciences, John and his team are revolutionizing drug discovery through AI and machine learning. Under John’s leadership, the team works in harmony with AI to establish a powerful new tempo for drug development: http://spr.ly/6180t
429 viewsDec 4, 2024
FacebookGenentech
Ensuring everyone has access to equitable healthcare requires closing gaps in care, including for rural and underserved communities affected by multiple sclerosis (MS). We recently brought together more than 100 patients, providers and advocates for a community dialogue in Phoenix, Arizona, and heard that limited access to MS specialists continues to pose major challenges for patients and providers alike. When we work together, we can convert community insights into practical, sustainable soluti
0:29
Ensuring everyone has access to equitable healthcare requires closing gaps in care, including for rural and underserved communities affected by multiple sclerosis (MS). We recently brought together more than 100 patients, providers and advocates for a community dialogue in Phoenix, Arizona, and heard that limited access to MS specialists continues to pose major challenges for patients and providers alike. When we work together, we can convert community insights into practical, sustainable soluti
72.7K views7 months ago
FacebookGenentech
Genentech announces another round of mass layoffs in South San Francisco
Genentech announces another round of mass layoffs in South San Francisco
8 months ago
sfchronicle.com
Biotech company Genentech breaks ground in Holly Springs
Biotech company Genentech breaks ground in Holly Springs
7 months ago
wral.com
Introducing the new and improved Centennial Way Dog Park! As a part of our annual Genentech Gives Back Week, employees came together to build a playground for our local four-legged friends to run, jump and play. Giving back is core to who we are, and we're proud to partner with the South San Francisco Parks and Recreation Department to make our community a better place for everyone, including our furry companions like Sabi! Learn more about our Gives Back Week tradition: http://spr.ly/6182ADkEu
0:53
Introducing the new and improved Centennial Way Dog Park! As a part of our annual Genentech Gives Back Week, employees came together to build a playground for our local four-legged friends to run, jump and play. Giving back is core to who we are, and we're proud to partner with the South San Francisco Parks and Recreation Department to make our community a better place for everyone, including our furry companions like Sabi! Learn more about our Gives Back Week tradition: http://spr.ly/6182ADkEu
153.9K views7 months ago
FacebookGenentech
Biotech company Genentech breaks ground in Holly Springs
0:48
Biotech company Genentech breaks ground in Holly Springs
7 months ago
cbs17.com
GENENTECH: A Rich History of Chemical Engineering Innovation
GENENTECH: A Rich History of Chemical Engineering Innovation
Aug 11, 2023
aiche.org
For nearly 50 years, our expertise in blood cancer has driven us to turn cutting-edge science into meaningful medical breakthroughs. But innovation alone isn’t enough. We’re relentlessly working to ensure people living with blood cancer can access the treatments they need and meeting them where they are by collaborating closely with community oncologists and advocates across the country to help reduce the burdens of treatment. #BloodCancerAwarenessMonth | Genentech
0:40
For nearly 50 years, our expertise in blood cancer has driven us to turn cutting-edge science into meaningful medical breakthroughs. But innovation alone isn’t enough. We’re relentlessly working to ensure people living with blood cancer can access the treatments they need and meeting them where they are by collaborating closely with community oncologists and advocates across the country to help reduce the burdens of treatment. #BloodCancerAwarenessMonth | Genentech
207.4K views6 months ago
FacebookGenentech
Many personalized cancer treatments aim to block out-of-control signals that fuel tumor growth. Targeting the PI3K pathway, which drives the growth of many cancers including #breastcancer, has been a challenging goal for researchers. Anwesha Dey, Senior Director & Scientist in Discovery Oncology at Genentech, uses everyday objects to explain how discoveries are enabling a new scientific advancement which not only blocks mutated signals, but also destroys the mutated proteins. | Genentech
1:31
Many personalized cancer treatments aim to block out-of-control signals that fuel tumor growth. Targeting the PI3K pathway, which drives the growth of many cancers including #breastcancer, has been a challenging goal for researchers. Anwesha Dey, Senior Director & Scientist in Discovery Oncology at Genentech, uses everyday objects to explain how discoveries are enabling a new scientific advancement which not only blocks mutated signals, but also destroys the mutated proteins. | Genentech
274.9K viewsNov 14, 2024
FacebookGenentech
Julia, diagnosed HER2-positive, explains why it's important for everyone to understand that breast cancer is not a one-size-fits-all disease. Watch as she shares why being more informed is important for both patients and their loved ones. https://bit.ly/2uqk2JV | Genentech
0:23
Julia, diagnosed HER2-positive, explains why it's important for everyone to understand that breast cancer is not a one-size-fits-all disease. Watch as she shares why being more informed is important for both patients and their loved ones. https://bit.ly/2uqk2JV | Genentech
234.2K viewsAug 17, 2018
FacebookGenentech
There are a lot of considerations when choosing the right biotech partner. James Sabry explains why value creation is the most important factor to us. | Genentech
0:22
There are a lot of considerations when choosing the right biotech partner. James Sabry explains why value creation is the most important factor to us. | Genentech
39.5K viewsJun 8, 2016
FacebookGenentech
Biomarker testing was an important part of Shirley’s cancer journey. When she was diagnosed with cancer in her early 30s, her doctors tested her cancer for biomarkers. The results showed a mutation called ALK. With this knowledge, her doctors were able to develop a plan to treat her specific cancer. Learn more about biomarker testing and Shirley’s story: https://bit.ly/3sTw9AR | Genentech
0:45
Biomarker testing was an important part of Shirley’s cancer journey. When she was diagnosed with cancer in her early 30s, her doctors tested her cancer for biomarkers. The results showed a mutation called ALK. With this knowledge, her doctors were able to develop a plan to treat her specific cancer. Learn more about biomarker testing and Shirley’s story: https://bit.ly/3sTw9AR | Genentech
81.2K viewsNov 28, 2023
FacebookGenentech
Do you know what questions to ask if you or a loved one is diagnosed with breast cancer? Learn more about the different types of the disease and questions to ask your doctor. | Genentech
0:16
Do you know what questions to ask if you or a loved one is diagnosed with breast cancer? Learn more about the different types of the disease and questions to ask your doctor. | Genentech
72.8K viewsNov 28, 2019
FacebookGenentech
Megan knew breast cancer was a major health challenge, but she had no idea there were so many different types or treatment options until she was diagnosed. | Genentech
1:13
Megan knew breast cancer was a major health challenge, but she had no idea there were so many different types or treatment options until she was diagnosed. | Genentech
257.9K viewsOct 11, 2019
FacebookGenentech
Jeff, a non-small cell lung cancer survivor, shares what he's learned since his diagnosis and what his message is to others who are newly diagnosed. #LCAM | Genentech
1:10
Jeff, a non-small cell lung cancer survivor, shares what he's learned since his diagnosis and what his message is to others who are newly diagnosed. #LCAM | Genentech
57.7K viewsNov 19, 2018
FacebookGenentech
See more